Advice Pool - Health and Fitness

Young individuals present with history of redness of eyes and mild blurring of one of the eyes. This blurring slowly progresses and also he

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

gets pain and photophobia (difficulty in facing the powerful sunlight.) and also watering. This is the usual presentation of the Iritis- the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

infection of the iris. Mostly these symptoms appear in only one eye, the other eye may also get affected later.

Iris is a curtain-like oute

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

tissue encircling the pupil, behind the cornea. It is the one which gives the color to the eye which we describe variously as black eye, br

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

own eye etc., Iritis or Iridocyclitis is a serious disease of the eye. Generally it is mistaken for simple conjunctivitis or red eye. As a r

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

sult patient wastes plenty of time before consulting an Eye-specialist. The problem is if the patient starts treatment in the late phase of

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

he disease, even the best of treatment will not prevent damage to the structure and function of the eye. In the anterior uveitis or iritis,

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

the iris is affected in different grades depending on the severity of the disease. With the result, the pupil which is normally round gets d

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

formed or go out of shape. Sometimes different types of exudates would accumulate in the papillary area or anterior chamber.

The Eye-specia

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ist has to find the cause of iritis. He usually recommends blood and urine tests and, if the cough is severe then the sputum examination als

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

has to be done. In spite of these tests, many a time the cause may not be detected. Then the treatment becomes difficult.

The Eye surgeon

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

has to treat the patient empirically , with the assumption that the infection is somewhere in the body. Sometimes diseases like Syphilis, Go

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

orrhoea, Leprosy and Tuberculosis may be causative factor for the disease. Then the treatment becomes comparatively easy. Some allergic reac

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ion in the body may also cause iritis.

Early diagnosis and treatment has beneficial effects. Steroid and atropine eye drops, systemic stero

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

id ( steroid given in the form of tablets or injections) and systemic antibiotics are given. This requires a prolonged treatment. Some patie

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ts do not complete the course of the treatment, with the result the disease recurs. If the treatment is not taken properly or otherwise also

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

due to the severity of the disease, there would be disastrous effects. Iris shrinks in different proportions resulting in what is known as s

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ynechia. The clear normal lens of the eye also gets affected resulting in complicated cataract causing complete blindness. If the disease go

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

s beyond this stage, it would make the eyeball small and useless- Pthisis Bulbi. The treatment is not effective in advanced phase of the dis

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ase. That is why it is very important to diagnose at the early stage of the disease and institute methodic treatment, which would be helpful

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/246562/advicepool-Iritis--The-Serious-Disease-Of-The-Eye.html">Iritis - The Serious Disease Of The Eye</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/246562/advicepool-Iritis--The-Serious-Disease-Of-The-Eye.html]Iritis - The Serious Disease Of The Eye[/url]

In the future mankind may need to be able to break up Comets, Asteroids and Meteors that are headed for Earth. In doing so we may need to further insure that we are able to use abatement procedures to further break down the size of the larger comet fragments to protect human civilizations. But how can we do this safely?

Muscles move joints, to which they are joined, by shortening and pulling one end of the muscle closer to the other end. A muscle is made up of lots and lots of muscle fibres which are held together in bundles. The muscle fibres are activated by the brain sending electrical impulses to each muscle fibre via the nerves.

Tags

Links

Advice Pool - Iritis - The Serious Disease Of The Eye

Related Articles: